- Home
- HOUR vs OCUP Comparison
HOUR vs OCUP Comparison
Compare HOUR & OCUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOUR
- OCUP
- Stock Information
- Founded
- HOUR 2015
- OCUP 2018
- Country
- HOUR United States
- OCUP United States
- Employees
- HOUR N/A
- OCUP N/A
- Industry
- HOUR Catalog/Specialty Distribution
- OCUP Biotechnology: Pharmaceutical Preparations
- Sector
- HOUR Consumer Discretionary
- OCUP Health Care
- Exchange
- HOUR Nasdaq
- OCUP Nasdaq
- Market Cap
- HOUR 50.2M
- OCUP 53.1M
- IPO Year
- HOUR 2022
- OCUP N/A
- Fundamental
- Price
- HOUR $1.43
- OCUP $1.25
- Analyst Decision
- HOUR
- OCUP Strong Buy
- Analyst Count
- HOUR 0
- OCUP 3
- Target Price
- HOUR N/A
- OCUP $18.67
- AVG Volume (30 Days)
- HOUR 8.8K
- OCUP 90.1K
- Earning Date
- HOUR 11-11-2024
- OCUP 11-11-2024
- Dividend Yield
- HOUR N/A
- OCUP N/A
- EPS Growth
- HOUR N/A
- OCUP N/A
- EPS
- HOUR 0.04
- OCUP N/A
- Revenue
- HOUR $141,390,974.00
- OCUP $16,449,000.00
- Revenue This Year
- HOUR $39.97
- OCUP N/A
- Revenue Next Year
- HOUR N/A
- OCUP $258.69
- P/E Ratio
- HOUR $39.72
- OCUP N/A
- Revenue Growth
- HOUR 25.95
- OCUP N/A
- 52 Week Low
- HOUR $0.83
- OCUP $1.15
- 52 Week High
- HOUR $2.20
- OCUP $3.40
- Technical
- Relative Strength Index (RSI)
- HOUR 54.28
- OCUP 44.19
- Support Level
- HOUR $1.40
- OCUP $1.24
- Resistance Level
- HOUR $1.55
- OCUP $1.39
- Average True Range (ATR)
- HOUR 0.07
- OCUP 0.07
- MACD
- HOUR -0.01
- OCUP -0.00
- Stochastic Oscillator
- HOUR 21.40
- OCUP 22.22
About HOUR Hour Loop Inc.
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
About OCUP Ocuphire Pharma Inc.
Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting the front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema.